Nesiritide Injection

Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of nesiritide injection in China. Welcome to wholesale bulk high quality nesiritide injection for sale here from our factory. Good service and reasonable price are available.

Nesiritide injection is a dedicated intravenous medication widely used for emergency diagnosis and treatment of acute decompensation of severe cardiac insufficiency in cardiovascular care. Its active ingredient nesiritide carries the CAS number 174689-39-1, a recombinant polypeptide compound presented as white or off-white lyophilized powder in its raw form. This substance boasts favorable water solubility, allowing quick dissolution in standard diluents for clinical infusion. When stored in sealed containers under cool, dry and light-shielded conditions, it maintains stable molecular structure and full biological activity over the shelf life; exposure to high temperature or prolonged humidity may trigger protein denaturation and compromise its therapeutic potency.

This agent delivers definite clinical benefits across its applicable scenarios and pharmacological profiles. Combined with its reliable physicochemical properties, it exerts prominent effects on diuresis and natriuresis, modulates cardiac filling pressure and rapidly alleviates acute clinical symptoms associated with cardiac insufficiency. This elaboration follows objective and rigorous standards, covering its targeted patient groups, distinct efficacy traits as well as common and manageable adverse reactions. It clarifies the core clinical value and essential administration guidelines of the drug in practical application, offering well-defined references for clinical diagnosis, intervention and rational medication selection in cardiovascular emergency settings.

Nesiritide COA

Certificate of Analysis
Compound name	Nesiritide
Grade	Pharmaceutical grade
CAS No.	124584-08-3
Quantity	36g
Packaging standard	PE bag+Al foil bag
Manufacturer	Shaanxi BLOOM TECH Co., Ltd
Lot No.	202501090068
MFG	Jan 9th 2026
EXP	Jan 8th 2029
Structure
Item	Enterprise standard	Analysis result
Appearance	White or almost white powder	Conformed
Water content	≤5.0%	0.54%
Loss on drying	≤1.0%	0.42%
Heavy Metals	Pb≤0.5ppm	N.D.
	As≤0.5ppm	N.D.
	Hg≤0.5ppm	N.D.
	Cd≤0.5ppm	N.D.
Purity (HPLC)	≥99.0%	99.98%
Single impurity	<0.8%	0.52%
Total microbial count	≤750cfu/g	95
E. Coli	≤2MPN/g	N.D.
Salmonella	N.D.	N.D.
Ethanol (by GC)	≤5000ppm	500ppm
Storage	Store in a sealed, dark, and dry place below -20°C

Which further exacerbates pulmonary congestion and systemic edema, to reverse this abnormal physiological state and relieve cardiac burden fundamentally, the drug exerts targeted regulatory effects on renal water and salt metabolism. Its potent diuretic and natriuretic properties serve as one of the most essential and foundational pharmacological mechanisms for improving cardiac insufficiency conditions, effectively correcting fluid retention and hemodynamic disorders through multi-dimensional regulation of renal excretory function.

Diuretics and sodium excretion: increase urine output, reduce blood volume

• Diuretic and sodium excretion is one of the most fundamental key roles of this drug, with its target directly directed towards the body's water and salt metabolism. By regulating the renal excretion role, it achieves the elimination of excess water and sodium ions from the body.
• Increase urine output: drugs can promote the kidney to generate and discharge more urine, so that the water trapped in the body can be quickly discharged from the body through the urinary system, improve the urine output per unit time, and improve the state of water retention in the body.

• Reduce blood volume: As excess water is continuously excreted from the body, the total fluid volume in the systemic blood circulation will correspondingly decrease, directly reducing the circulating blood volume. Excessive blood volume can increase the burden of pumping blood in the heart. By reducing blood volume, the capacity load on the heart can be alleviated from the root, creating a foundation for the recovery of heart role.

Reduce heart filling pressure: relieve pulmonary congestion and breathing difficulties

• Cardiac filling pressure refers to the pressure inside the ventricles during diastole. In acute cardiac insufficiency, the heart's pumping ability decreases, making it difficult for blood to flow out smoothly, resulting in an abnormal increase in cardiac chamber filling pressure.
• This drug can effectively reduce heart filling pressure and relieve abnormal conditions of high heart chamber pressure by regulating cardiac load, allowing the diastolic and systolic role of the heart to return to a relatively stable state.

• Relieve pulmonary congestion: When the heart filling pressure is too high, blood will accumulate in the pulmonary blood vessels, forming pulmonary congestion; After the decrease in filling pressure, the blood accumulated in the lungs can gradually flow back, and the pathological state of pulmonary congestion is directly improved.
• Relieve respiratory distress: Pulmonary congestion can compress the lungs, affecting their normal ventilation and air exchange role, leading to symptoms such as chest tightness, wheezing, and difficulty breathing in patients; With the reduction of pulmonary congestion and the restoration of lung gas exchange role, the patient's respiratory distress symptoms can be significantly relieved.

Used for hospitalized patients with acute decompensated heart failure

(I)Limitations on applicable conditions: Nesiritide injection is only used for acute decompensated cardiac insufficiency, which refers to patients with pre-existing cardiac insufficiency who suddenly experience acute exacerbation of the condition, or sudden acute cardiac insufficiency with rapid deterioration of cardiac role, and belong to cardiovascular emergencies.(II)Target audience: Only applicable to hospitalized patients, not used in outpatient, home and other non inpatient scenarios. As acute decompensated heart failure is a critical emergency, multiple indicators such as electrocardiogram, blood pressure, and renal role need to be monitored in the hospital to ensure medication safety.(III)Strictly exclusive usage scenario: only used for inpatient intervention of acute decompensated cardiac insufficiency, not for long-term maintenance intervention of chronic cardiac insufficiency, nor extended to the intervention of other heart diseases or non heart diseases. The patient-related utilization boundary is clear and strict.

key characteristics of drug efficacy time

• As an emergency intervention drug, the speed of onset of Naxilitide is its key drug advantage, it suitable for the rapid intervention needs of acute cardiac insufficiency emergencies. Its time effectiveness characteristics are distinct and prominent, as shown below:
• After intravenous administration of drugs, the pharmacological effects are triggered quickly and the onset rhythm is fast, which can quickly meet the emergency intervention needs of patients with acute cardiac insufficiency. It can gradually play a key regulatory role without long waiting, meeting the timeliness requirements of emergency diagnosis and intervention.

Common Adverse Drug Reaction Tips

During the patient-related utilization of Nesiritide injection, there may be a few mild or controllable adverse reactions, with fixed types of reactions and no complex extensions. The overall incidence is controllable and only requires simple patient-related attention. The specific common adverse reactions are as follows:During medication, occasional physical discomfort such as hypotension, headache, and nausea may occur, and some patients may experience slight fluctuations in renal role indicators. The overall adverse reactions are singular, with no other rare or serious associated reactions.

As a highly targeted intravenous therapeutic agent specifically developed for the emergency intervention of severe acute cardiac insufficiency, nesiritide possesses precise clinical positioning and exclusive pharmacological orientation, distinguishing it from conventional comprehensive cardiovascular medications. It is uniquely indicated for inpatients diagnosed with acute decompensated cardiac insufficiency, focusing precisely on improving acute hemodynamic disorders and critical clinical symptoms caused by cardiac functional deterioration. Unlike broad-spectrum cardiovascular drugs with multiple trivial pharmacological effects and wide applicable populations.

This drug features highly targeted therapeutic properties without redundant off-target pharmacological activities, enabling it to concentrate efficacy on the core pathological links of acute cardiac insufficiency and avoid unnecessary physiological interference to the body. The rapid and efficient emergency intervention capacity of nesiritide is mainly realized through two core and synergistic pharmacological mechanisms.On the one hand, the drug targets the renal water-salt metabolic pathway to exert significant diuretic and natriuretic effects. It effectively promotes the excretion of excess water and sodium accumulated in the body, significantly increases urine output, and continuously reduces excessive circulating blood volume.

This intervention fundamentally improves the systemic circulatory overload state caused by fluid retention, relieves excessive cardiac preload, and reverses the hemodynamic imbalance that worsens cardiac insufficiency.On the other hand, nesiritide can effectively reduce ventricular end-diastolic pressure and overall cardiac filling pressure, directly alleviate pulmonary venous congestion and interstitial edema, and rapidly improve intractable respiratory distress, hypoxemia and other critical symptoms that severely plague patients with acute cardiac insufficiency. Furthermore, benefited from its stable pharmacological activity and rapid pharmacokinetic characteristics after intravenous infusion.

References

Li Weimin, Li Yue Practical cardiac insufficiency Studies [M]. Beijing: People's Health Press, 2016

Editorial Department of Chinese Journal of Hospital Pharmacy Safety evaluation of patient-related utilization of Naxilitide [J]. Chinese Journal of Hospital Pharmacy, 2008, 28 (15): 1297-1299

FAQ

• What type of drug is nesiritide injection?

This medicinal product is a clinically approved preparation of human B-type natriuretic peptide, which is biosynthesized via advanced recombinant DNA technology. It is routinely prescribed for the treatment of patients diagnosed with acute cardiac insufficiency. Pharmacologically, nesiritide possesses moderate natriuretic activity and functions as a systemic vasodilator to regulate vascular tension across the body.

• Is it a vasodilator?

Nesiritide is a recombinant form of human B-type natriuretic peptide, formulated for intravenous administration as a potent vasodilator. It is primarily indicated for the treatment of patients with acutely decompensated cardiac insufficiency. Apart from its mild diuretic and natriuretic effects that help regulate fluid and electrolyte balance, this agent effectively lowers intracardiac filling pressures, elevates the cardiac index, and ultimately relieves the uncomfortable clinical symptoms associated with the condition.

• Is nesiritide FDA approved?

This pharmaceutical agent has received official marketing approval from the U.S. Food and Drug Administration (FDA) for clinical application. It is specifically indicated for short-term intravenous intervention in patients diagnosed with acutely decompensated congestive cardiac insufficiency (CHF). The medication is primarily intended for individuals troubled by persistent and noticeable dyspnea, also known as shortness of breath, a distressing symptom that manifests not only during slight physical exertion but also while the patients remain completely at rest. By delivering targeted therapeutic effects through intravenous infusion, it helps alleviate severe respiratory discomfort and improve the overall clinical status of this patient group.

Hot Tags: nesiritide injection, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale